Prostate Cancer - Results from #19960

PSA density improves prediction of prostate cancer - Abstract August 8, 2014

The influence of prostate volume in prostate health index performance in patients with total PSA lower than 10μg/L - Abstract August 8, 2014

Implementation of the S3 prostate cancer guideline in daily clinical practice: Results of a survey among urologists - Abstract August 8, 2014

Guideline of guidelines: Prostate cancer screening - Abstract August 8, 2014

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology? - Abstract August 8, 2014

Two different intensity-modulated radiotherapy strategies for patients with high-risk prostate cancer - Abstract August 8, 2014

The incidence of postoperative ileus in patients who underwent robotic assisted radical prostatectomy - Abstract August 8, 2014

Neoadjuvant before surgery treatments: State of the art in prostate cancer - Abstract August 8, 2014

Comparison of fracture risk assessment tool score to bone mineral density for estimating fracture risk in patients with advanced prostate cancer on androgen deprivation therapy - Abstract August 8, 2014

Accuracy of transrectal ultrasonography to evaluate pathologic prostate weight: Correlation with various prostate size groups - Abstract August 8, 2014

Effect of caffeine on exercise capacity and function in prostate cancer survivors - Abstract August 8, 2014

Incidental diagnosis of diffuse large B-cell lymphoma by 11C-choline PET/CT in a patient with biochemical recurrence of prostate cancer - Abstract August 8, 2014

Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging - Abstract August 7, 2014

Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy - Abstract August 7, 2014

Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): An open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial - Abstract August 7, 2014

Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer - Abstract August 7, 2014

The association between insurance status and prostate cancer outcomes: Implications for the Affordable Care Act - Abstract August 7, 2014

"It's all very well reading the letters in the genome, but it's a long way to being able to write": Men's interpretations of undergoing genetic profiling to determine future risk of prostate cancer - Abstract August 7, 2014

Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up - Abstract August 6, 2014

Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network Risk Groups - Abstract August 6, 2014

Page 999 of 1436